+44 203 371 1100
+44 203 371 1100
Credit Sector:- Health Care
Country:- United States
Bond Document:- https://www.bondpdf.com
In order to view the complete data, please login here
| Announcement Date | CA Type | CA Impact | CA Event | ISIN |
|---|---|---|---|---|
| 23-Feb-2023 | New Bond | - | - | US532457CH90 |
| Eli Lilly and Company today announced that it has issued USD 1MMM, 4.95% Fixed bond due 27-Feb-2063. | ||||
| 23-Feb-2023 | New Bond | - | - | US532457CG18 |
| Eli Lilly and Company today announced that it has issued USD 1250MM, 4.875% Fixed bond due 27-Feb-2053. | ||||
| 23-Feb-2023 | New Bond | - | - | US532457CF35 |
| Eli Lilly and Company today announced that it has issued USD 1MMM, 4.700% Fixed bond due 27-Feb-2033. | ||||
| 23-Feb-2023 | New Bond | - | - | US532457CE69 |
| Eli Lilly and Company today announced that it has issued USD 750MM, 5.0% Fixed bond due 27-Feb-2026. | ||||
| 03-Oct-2023 | Propose Acquisition | Target Name | POINT Biopharma Inc. | US00214WAE12 |
| Eli Lilly and Company today announced that it intends to acquire POINT Biopharma Inc.. | ||||
All of the financial data available on this page is sourced from FactEntry.